Feasibly of CD24/CD11b as a Screening Test for Hematological Malignancies

Role of Circulating Tumor DNA in Hematological Malignancy

(2021) Miho Ogawa et al.   Cancers

Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening

(2019) Robert A. Smith et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma

(2019) Minjie Gao et al.   JNCI-Journal of the National Cancer Institute

Inhibition of Sonic Hedgehog Signaling Pathway by Thiazole Antibiotic Thiostrepton Attenuates the CD44+/CD24-Stem-Like Population and Sphere-Forming Capacity in Triple-Negative Breast Cancer

(2016) Na Yang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

The role of CD24 in multiple myeloma tumorigenicity and the effect of the microenvironment on CD24 expression

(2016) Nechama Gilad et al.   EXPERIMENTAL HEMATOLOGY

Predictive Levels of CD24 in Peripheral Blood Leukocytes for the Early Detection of Colorectal Adenomas and Adenocarcinomas

(2015) Sarah Kraus et al.   DISEASE MARKERS

Biomarkers in Hematological Malignancies: A Review of Molecular Testing in Hematopathology

(2015) Mohammad Hussaini   Cancer Control

Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis

(2014) M R Corces-Zimmerman et al.   LEUKEMIA

Cancer Biomarkers: Are We Ready for the Prime Time?

(2010) Alok Mishra et al.   Cancers

The novel oncogeneCD24and its arising role in the carcinogenesis of the GI tract: from research to therapy

(2008) Eyal Sagiv et al.   Expert Review of Gastroenterology & Hepatology